International Clinical Trial: A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121192) titled 'A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: GlaxoSmithKline

Condition: Influenza, Human

Intervention: Biological: Flu mRNA (Formulation A) Biological: Flu mRNA (Formulation B) Combination Product: Comparator 1 Combination Product: Comparator 2

Recruitment Status: Not recruiting

Phase: Phase 2

D...